At a glance
ClinicalIndex Comparison RecordN/ACompleted· 264 enrolled
Drug / intervention
Antibacterial agent for the treatment of febrile neutropeniadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Center, Non-Interventional, Observational Study To Evaluate The Antibacterial Therapeutical Options In Febrile Neutropenia Patients
In Brief
An observational study evaluating Antibacterial agent for the treatment of febrile neutropenia for Febrile Neutropenia. Completed, enrolled 264 participants across 5 sites.
Detailed Summary
The purpose of this study was to define and classify antibacterial agents used in Turkey for patients with febrile neutropenia.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFebrile Neutropenia
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
First PostedJul 2009
Primary CompletionOct 2010
TodayJul 2026
First PostedJul 24, 2009
Enrollment StartJun 1, 2009
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.9 years ago
Interventions
Antibacterial agent for the treatment of febrile neutropeniadrug
The antibacterial agent used by the investigators for febrile neutropenia will be determined and classified in the preference order